2014Xiandai shengwu yixue jinzhanRequires access

Study on Dynamic Changes and Correlation of Serum Levels of Transforming Growth Factor β1 and Radiation-induced Hepatic Fibrosis in Rat

Wang Yun-lia

Open publisher page 0 citations

Abstract

Objective: Radiation therapy of liver carcinoma may lead to the complication of radiation- induced liver disease(RILD), hepatic fibrosis, even hepatic cirrhosis. So it is of great significance to look for better serum markers for noninvasively diagnosing and monitoring radiation-induced hepatic fibrosis. In this study, we established the rats model of radiation-induced hepatic fibrosis,detected the dynamic changes of serum levels of transforming growth factor beta 1(TGF-β1), explored the correlation of TGF-β1 and the severity of radiation-induced hepatic fibrosis, and discovered the diagnosis value of TGF-β1. Methods: Forty healthy male Sprague-Dawley rats were randomly divided into model group(30 rats) and control group(10 rats). The right-half of rat liver in model group was irradiated with a single dose of 25 Gy to establish radiation-induced hepatic fibrosis model. Liver tissues from the irradiated liver, and blood sample were collected at different time points(2 months, 4 months, 6 months) after irradiation. Expression of TGF-β1 by enzyme-linked immunosorbent assay(ELISA) was performed. Pathomorphological change in the liver was observed with hematoxylineosin staining by optical microscope. Results: The expression of serum TGF-β1 of model group at different time points [2 months,(551.03±69.00) ng/L; 4 months,(645.31±109.29) ng/L; 6 months,(737.89±118.11) ng/L] was significantly higher than that of the control group(451.71±51.12 ng/L, P0.05). There were distinctly positive correlation between the serum of TGF-β1 value and severity of hepatic fibrosis(r=0.82, P0.01). Conclusion: In the development of radiation- induced fibrosis, TGF-β1 rises with the severity of hepatic fibrosis. We provide a new noninvasive and convenient means for monitoring the severity of hepatic fibrosis, and lay a theoretical foundation for subsequent TGF-β1 as a serum marker applied to clinical research of radiation-induced hepatic fibrosis.

About this research paper

What this paper is about

Objective: Radiation therapy of liver carcinoma may lead to the complication of radiation- induced liver disease(RILD), hepatic fibrosis, even hepatic cirrhosis. So it is of great significance to look for better serum markers for noninvasively diagnosing and monitoring radiation-induced hepatic fibrosis. In this study, we established the rats model of radiation-induced hepatic fibrosis,detected the dynamic changes of serum levels of transforming growth factor beta 1(TGF-β1), explored the correlation of TGF-β1 and the severity of radiation-induced hepatic fibrosis, and discovered the diagnosis value of TGF-β1. Methods: Forty healthy male Sprague-Dawley rats were randomly divided into model group(30 rats) and control group(10 rats). The right-half of rat liver in model group was irradiated with a single dose of 25 Gy to establish radiation-induced hepatic fibrosis model. Liver tissues from the irradiated liver, and blood sample were collected at different time points(2 months, 4 months, 6 months) after irradiation. Expression of TGF-β1 by enzyme-linked immunosorbent assay(ELISA) was performed. Pathomorphological change in the liver was observed with hematoxylineosin staining by optical microscope. Results: The expression of serum TGF-β1 of model group at different time points [2 months,(551.03±69.00) ng/L; 4 months,(645.31±109.29) ng/L; 6 months,(737.89±118.11) ng/L] was significantly higher than that of the control group(451.71±51.12 ng/L, P0.05). There were distinctly positive correlation between the serum of TGF-β1 value and severity of hepatic fibrosis(r=0.82, P0.01). Conclusion: In the development of radiation- induced fibrosis, TGF-β1 rises with the severity of hepatic fibrosis. We provide a new noninvasive and convenient means for monitoring the severity of hepatic fibrosis, and lay a theoretical foundation for subsequent TGF-β1 as a serum marker applied to clinical research of radiation-induced hepatic fibrosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: Radiation therapy of liver carcinoma may lead to the complication of radiation- induced liver disease(RILD), hepatic fibrosis, even hepatic cirrhosis. So it is of great significance to look for better serum markers for noninvasively diagnosing and monitoring radiation-induced hepatic fibrosis. In this study, we established the rats model of radiation-induced hepatic fibrosis,detected the dynamic changes of serum levels of transforming growth factor beta 1(TGF-β1), explored the correlation of TGF-β1 and the severity of radiation-induced hepatic fibrosis, and discovered the diagnosis value of TGF-β1. Methods: Forty healthy male Sprague-Dawley rats were randomly divided into model group(30 rats) and control group(10 rats). The right-half of rat liver in model group was irradiated with a single dose of 25 Gy to establish radiation-induced hepatic fibrosis model. Liver tissues from the irradiated liver, and blood sample were collected at different time points(2 months, 4 months, 6 months) after irradiation. Expression of TGF-β1 by enzyme-linked immunosorbent assay(ELISA) was performed. Pathomorphological change in the liver was observed with hematoxylineosin staining by optical microscope. Results: The expression of serum TGF-β1 of model group at different time points [2 months,(551.03±69.00) ng/L; 4 months,(645.31±109.29) ng/L; 6 months,(737.89±118.11) ng/L] was significantly higher than that of the control group(451.71±51.12 ng/L, P0.05). There were distinctly positive correlation between the serum of TGF-β1 value and severity of hepatic fibrosis(r=0.82, P0.01). Conclusion: In the development of radiation- induced fibrosis, TGF-β1 rises with the severity of hepatic fibrosis. We provide a new noninvasive and convenient means for monitoring the severity of hepatic fibrosis, and lay a theoretical foundation for subsequent TGF-β1 as a serum marker applied to clinical research of radiation-induced hepatic fibrosis.

Key concepts: Cirrhosis, Hepatic fibrosis, Medicine, Fibrosis, Internal medicine, Transforming growth factor, Hepatocellular carcinoma, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on Dynamic Changes and Correlation of Serum Levels of Transforming Growth Factor β1 and Radiation-induced Hepatic Fibrosis in Rat — Research Paper | ScholarLens